Background\nMyocardial infarction (MI) is the leading cause of death in Iran. Every attempt to improve\ntreatment patterns and patient outcomes needs a surveillance system to both consider the\nefficacy and safety measures. Fasa Registry on Myocardial Infarction (FaRMI) is the first\npopulation-based registry for acute MI in Iran targeted to provide meticulous description of\npatients� characteristics, to explore the management patterns of these patients, to discover\nthe degree of adherence to the practice guidelines, and to investigate the determinants of\npoor in-hospital and later outcomes.\nMethods\nA diagnosis of acute MI (type I, II and III) was made upon the accepted criteria by the attending\ncardiologists and types IV and V MI were excluded. Two registrar nurses gathered data\non demographics, place of residence and ethnicity, past medical history, risk factors, and\nthe clinical course. Management patterns in the pre-hospital setting, during the hospital stay\nand at the discharge time were recorded. Routine laboratory results and cardiac biomarkers\non three consecutive days were registered.\nResults\npilot phase included the first 95 patients, 63.5% of whom were men and 31.5% were\nwomen. With a mean age of 62.8913.75 years among participants, the rate of premature\nMI was 31.8%. ST segment elevation MI accounted for 68.2% cases and inferior wall was\nthe most prevalent region involved followed by anterior and posterior walls. Discussion\nObtained data on the characteristics of patients suffering an MI event revealed the major\ndeterminants of delay in initiation of therapies and contributors of poor outcome. Completeness\nof data was guaranteed upon involvement of multiple checkpoints and data quality was\nsecured by means of automatic validation processes in addition to weekly physicians�\nroundups.\nConclusion\nExecution of FaRMI in the form presented is feasible and it will build up a comprehensive\npopulation-based registry for MI in the region.
Loading....